Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment
The global health crisis and economic tolls of COVID-19 necessitate a panoply of strategies to treat SARS-CoV-2 infection. To date, few treatment options exist, although neutralizing antibodies against the spike glycoprotein have proven to be effective. Because infection is initiated at the mucosa a...
שמור ב:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2021-01-01
|
| סדרה: | mAbs |
| נושאים: | |
| גישה מקוונת: | https://www.tandfonline.com/doi/10.1080/19420862.2021.1987180 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
